General discussion, page-14918

hi @malkazoid, I think anyone who has been paying attention gets your point. As you said, you've repeated it enough times.

You can talk about macro conditions till you're blue in the face and yes, anyone who can't see the impact of the macro conditions on a still speculative biotech with zero revenue is just not going to hear it.

But if you think the recent price action since the CR is majority based upon the prevailing macro conditions then I've got a bridge I'd like to sell you.